Kanghong Pharmaceuticals' oral solution of Aliquin has been approved by the State Drug Administration
-
Last Update: 2020-06-09
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
recently, Kanghong Pharmaceuticals announced that theof theCompany (http://received the "Drug Registration Approval" (batch number: 2019S00438) issued by the StateMedicines(http://Regulatory Authority on the oral solution of AliquinAbout Aliquinealiquinone as a new generation of antipsychoticdrug(http://, with small side effects, significant efficacy, low recurrence rate and other advantages, applicable to the long-term maintenance treatment of patients with schizophreniaThe oral solution of alistion belongs to category 3 of the chemical approved by the new registered classification of chemicals and is used to treat schizophreniaCompared with tablets, the relative advantage of oral solution is that it is more convenient to lower or adjust the dose, and has the advantages of improving patient compliance and solving swallowing difficultiesAfter querying the drug database of the State Drug Administration, as of now, there are no otherenterprises in China(http:// approved oral solution of Alyssium, Kanghong Pharmaceuticals for the first domestic enterprises to obtain the oral solution of Alyssium production approval
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
